About: OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. The company's pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate (ADC) silicone dioxide linker technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers. The company was incorporated in 2018 and is based in Grasonville, Maryland.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.73 (-4.95%)
Status: Delisted — removed_from_provider. This asset is no longer trading; historical data is shown.
OSTXNYSEOS Therapies Incorporated
Loading watchlist status…
OS Therapies Incorporated share price
OSTX price activity
Last Price
Change (24hr)
USD (%)
Volume
-
Volume (4w avg)
-
Previous Close
N/A
Last Trade
OSTX price performance
0%
5D
0%
1M
23.57%
YTD
-27.92%
1Y
OSTX price fundamentals
N/A
Shares Issued
N/A
Earnings Per Share (EPS)
N/A
Dividends Per Share (DPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
US-NYSE rank
N/ASector Rank
N/AOSTX details
OSTX Market Signals